BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15015071)

  • 1. NPHS2 mutation associated with recurrence of proteinuria after transplantation.
    Billing H; Müller D; Ruf R; Lichtenberger A; Hildebrandt F; August C; Querfeld U; Haffner D
    Pediatr Nephrol; 2004 May; 19(5):561-4. PubMed ID: 15015071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence.
    Weber S; Gribouval O; Esquivel EL; Morinière V; Tête MJ; Legendre C; Niaudet P; Antignac C
    Kidney Int; 2004 Aug; 66(2):571-9. PubMed ID: 15253708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence of proteinuria 10 years post-transplant in NPHS2-associated focal segmental glomerulosclerosis after conversion from cyclosporin A to sirolimus.
    Höcker B; Knüppel T; Waldherr R; Schaefer F; Weber S; Tönshoff B
    Pediatr Nephrol; 2006 Oct; 21(10):1476-9. PubMed ID: 16721582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence of focal-segmental glomerulosclerosis in children after renal transplantation: clinical and genetic aspects.
    Weber S; Tönshoff B
    Transplantation; 2005 Sep; 80(1 Suppl):S128-34. PubMed ID: 16286890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin.
    Bertelli R; Ginevri F; Caridi G; Dagnino M; Sandrini S; Di Duca M; Emma F; Sanna-Cherchi S; Scolari F; Neri TM; Murer L; Massella L; Basile G; Rizzoni G; Perfumo F; Ghiggeri GM
    Am J Kidney Dis; 2003 Jun; 41(6):1314-21. PubMed ID: 12776285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NPHS2 mutations in sporadic steroid-resistant nephrotic syndrome in Japanese children.
    Maruyama K; Iijima K; Ikeda M; Kitamura A; Tsukaguchi H; Yoshiya K; Hoshii S; Wada N; Uemura O; Satomura K; Honda M; Yoshikawa N
    Pediatr Nephrol; 2003 May; 18(5):412-6. PubMed ID: 12687458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome.
    Ruf RG; Lichtenberger A; Karle SM; Haas JP; Anacleto FE; Schultheiss M; Zalewski I; Imm A; Ruf EM; Mucha B; Bagga A; Neuhaus T; Fuchshuber A; Bakkaloglu A; Hildebrandt F;
    J Am Soc Nephrol; 2004 Mar; 15(3):722-32. PubMed ID: 14978175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid-resistant nephrotic syndrome.
    Carraro M; Caridi G; Bruschi M; Artero M; Bertelli R; Zennaro C; Musante L; Candiano G; Perfumo F; Ghiggeri GM
    J Am Soc Nephrol; 2002 Jul; 13(7):1946-52. PubMed ID: 12089392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The podocin mutation R229Q and early recurrence (within the first year) of glomerular disease after renal transplantation.
    Mohey H; Thibaudin L; Laurent B; Berthoux F
    Ann Transplant; 2013 Aug; 18():436-42. PubMed ID: 23982418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NPHS2 (podicin) mutations in Turkish children with idiopathic nephrotic syndrome.
    Berdeli A; Mir S; Yavascan O; Serdaroglu E; Bak M; Aksu N; Oner A; Anarat A; Donmez O; Yildiz N; Sever L; Tabel Y; Dusunsel R; Sonmez F; Cakar N
    Pediatr Nephrol; 2007 Dec; 22(12):2031-40. PubMed ID: 17899208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Heterozygotic mutation in NPHS2 gene as a cause of familial steroid resistant nephrotic syndrome in two siblings--case report].
    Drozdz D; Pietrzyk JA; Wierzchowska-Słowiaczek E; Sancewicz-Pach K; Antignac C; Miezyński W
    Przegl Lek; 2006; 63 Suppl 3():85-6. PubMed ID: 16898497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First Report of Recurrent Nephrotic Syndrome After Kidney Transplantation in a Patient With NUP93 Gene Mutations: A Case Report.
    Seeman T; Vondrak K
    Transplant Proc; 2018 Dec; 50(10):3954-3956. PubMed ID: 30577294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis.
    Caridi G; Bertelli R; Carrea A; Di Duca M; Catarsi P; Artero M; Carraro M; Zennaro C; Candiano G; Musante L; Seri M; Ginevri F; Perfumo F; Ghiggeri GM
    J Am Soc Nephrol; 2001 Dec; 12(12):2742-2746. PubMed ID: 11729243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report of novel genetic variation in NPHS2 gene associated with idiopathic nephrotic syndrome in South Indian children.
    Dhandapani MC; Venkatesan V; Rengaswamy NB; Gowrishankar K; Ekambaram S; Sengutavan P; Perumal V
    Clin Exp Nephrol; 2017 Feb; 21(1):127-133. PubMed ID: 26820844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mRNA sequencing of a novel NPHS2 intronic mutation in a child with focal and segmental glomerulosclerosis.
    Benetti E; Caridi G; Centi S; Vella MD; Ghiggeri GM; Artifoni L; Murer L
    Saudi J Kidney Dis Transpl; 2014 Jul; 25(4):854-7. PubMed ID: 24969201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in NPHS2 encoding podocin are a prevalent cause of steroid-resistant nephrotic syndrome among Israeli-Arab children.
    Frishberg Y; Rinat C; Megged O; Shapira E; Feinstein S; Raas-Rothschild A
    J Am Soc Nephrol; 2002 Feb; 13(2):400-405. PubMed ID: 11805168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic forms of nephrotic syndrome.
    Niaudet P
    Pediatr Nephrol; 2004 Dec; 19(12):1313-8. PubMed ID: 15503167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful Preemptive Kidney Transplantation With Rituximab Induction in a Patient With Focal Segmental Glomerulosclerosis and Massive Nephrotic Syndrome: A Case Report.
    Kolonko A; Piecha G; Więcek A
    Transplant Proc; 2016 Nov; 48(9):3092-3094. PubMed ID: 27932154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-Transplant Recurrence of Focal Segmental Glomerulosclerosis in a Child With Heterozygous Mutations in NPHS1 and NPHS2.
    Battelino N; Arnol M; Kandus A; Ponikvar R; Novljan G
    Ther Apher Dial; 2016 Jun; 20(3):312-7. PubMed ID: 27312921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NPHS2 homozygous p.R229Q variant: potential modifier instead of causal effect in focal segmental glomerulosclerosis.
    Kerti A; Csohány R; Wagner L; Jávorszky E; Maka E; Tory K
    Pediatr Nephrol; 2013 Oct; 28(10):2061-4. PubMed ID: 23800802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.